Trial · NCT05216757
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in patient's assessment of arthritis pain on a visual analogue scale | 12 weeks | Change from baseline in self-reported finger joint pain previous 48 hours on a 0-100 mm scale at 12 weeks of treatment; higher value indicate worse outcome. |
| Secondary | Change from baseline in patient's assessment of arthritis pain on a visual analogue scale prior to each visit | 4 weeks, 8 weeks, 12 weeks | Differences in self-reported finger joint pain previous 48 hours on a 0-100 mm scale at 4 weeks, 8 weeks, and 12 weeks; higher value indicate worse outcome. |
| Secondary | Change from baseline in Australian Canadian Hand Osteoarthritis Index (AUSCAN) scores at each visit. | 4 weeks, 8 weeks, 12 weeks | The AUSCAN Index is a self-administered questionnaire consisting of a 15-item scale which measures pain (5 items), stiffness (1 item) and degree of disability/physical function (9 items) during the preceding 48 hours; higher value indicate worse outcome. |
| Secondary | Change from baseline in Functional Index for Hand Osteoarthritis (FIHOA) | 12 weeks | The Functional Index for Hand Osteoarthritis (FIHOA) is a leading assessment tool for hand OA-related functional impairment; higher value indicate worse outcome. |
| Secondary | Change from baseline in Health Assessment Questionnaire Disability Index (HAQ) | 12 weeks | Change from baseline in Health Assessment Questionnaire Disability Index (HAQ) at week 12; higher value indicate worse outcome. |
| Secondary | Change from baseline in the Scores of SF-36 questionnaire | 12 weeks | Change from baseline in SF-36, including physical and mental component sores (PCS and MCS) at week 12; higher value indicate worse outcome. |
| Secondary | Change from baseline in Michigan Hand Outcomes Questionnaire (MHOQ) | 12 weeks | Michigan Hand Outcomes Questionnaire (MHOQ) pain and physical function subscales; function subscale range 10-50, higher value indicate worse outcome; task subscale range 17-85, higher value indicate worse outcome; work subscale range 5-25, higher value indicate worse outcome; pain subscale range 10-48, higher value indicate better outcome. |
| Secondary | Change from baseline in Ultrasound record | 12 weeks | Ultrasound record: number of finger joints with synovial thickening and power Doppler signals. |
| Secondary | Change from baseline in OMERACT hand OA magnetic resonance imaging score | 12 weeks | OMERACT hand OA magnetic resonance imaging score includes synovitis (0-3), erosive damage(0-3), cyst (0-3), osteophyte (0-3), cartilage space loss(0-3), malalignment (0-3), and bone marrow lesions (0-3); higher value indicate worse outcome |
| Other | Change from baseline in Erythrocyte Sedimentation Rate (ESR) | 12 weeks | Erythrocyte Sedimentation Rate (ESR); higher value indicate worse outcome. |
| Other | Change from baseline in C Reactive Protein (CRP) | 12 weeks | C Reactive Protein (CRP); higher value indicate worse outcome. |
| Other | Change from baseline in patient's global assessment of disease activity on a visual analogue scale | 12 weeks | Change from baseline in patient's global assessment of disease activity previous 48 hours on a 0-100 mm scale at 12 weeks of treatment; higher value indicate worse outcome. |
| Other | Change from baseline of physician's global assessment of disease activity on a visual analogue scale | 12 weeks | Change from baseline in physician's global assessment of disease activity previous 48 hours on a 0-100 mm scale at 12 weeks of treatment; higher value indicate worse outcome. |
| Other | Change from baseline in Fingertip-to-palm distance | 12 weeks | Change from baseline in Fingertip-to-palm distance, cm |
| Other | Change from baseline in grip strength | 12 weeks | Change from baseline in grip strength, kg |
| Other | Swelling and Tender joint count, assessed by physician joint count | 12 weeks | Swelling and Tender joint count, assessed by physician joint count |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05216757/registered